Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2025-12-26 @ 4:04 PM
NCT ID:
NCT06769906
Eligibility Criteria:
Inclusion Criteria:
* Patients for whom the use of a continuous glucose monitor has been determined based on the medical judgment of the attending physician.
* Insulin-treated type 2 diabetes patients, age 18-80 years old.
* Patients who have not changed their diabetes medication in the past 2 months.
* Patients with a glycated hemoglobin level between 6.5% and 12.0% within the last 3 months.
* Patients currently receiving insulin injection therapy, including basal insulin.
* Patients who have access to KakaoTalk via smartphone and are able to communicate with it.
* Voluntarily agreed to participate in this clinical study.
Exclusion Criteria:
* Steroid and immunosuppressant users. But it can be included if patients continuously maintain same drug dose at least three months.
* Patients who are currently taking weight control medications.
* Breastfeeding or pregnant patients
* Patients who do not voluntarily consent to the study
* Anyone deemed unsuitable by the investigator to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06769906
Study Brief:
Protocol Section:
NCT06769906